Zeit | Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
---|---|---|---|---|---|
26.03. | Recce Pharmaceuticals - R&D advance (A$11.18m) extends runway | 128 | Edison Investment Research | Recce Pharmaceuticals recently received A$11.18m as an R&D advance credit through an arrangement with Endpoints Capital for the R&D tax credit rebates that Recce expects to receive for FY23/FY24 and... ► Artikel lesen | |
26.03. | Immix Biopharma - Marching towards US clinical trials for NXC-201 | 252 | Edison Investment Research | Immix Biopharma is closer to dosing its first US patient for lead CAR-T asset NXC-201, with the appointment of the Memorial Sloan Kettering Cancer Center as the main clinical site for the company's... ► Artikel lesen |
Suchbegriffe der letzen 24 h | Anzahl |
---|---|
EVOTEC | 1.156 |
NEL | 697 |
BAYER | 675 |
TUI | 546 |
BYD | 518 |
DEUTSCHE BANK | 496 |
RWE | 446 |
NVIDIA | 427 |
MERCEDES-BENZ | 413 |
RHEINMETALL | 400 |
SUPER MICRO COMPUTER | 382 |
PLUG POWER | 367 |
TESLA | 359 |
AIXTRON SE | 319 |
RENK GROUP | 303 |
VOLKSWAGEN | 303 |
DEUTSCHE LUFTHANSA | 293 |
BIONTECH | 278 |
ALLIANZ | 274 |
PALANTIR TECHNOLOGIES | 265 |
COMMERZBANK | 264 |
BASF | 253 |
APPLE | 248 |
SIEMENS ENERGY | 248 |
DEUTSCHE POST | 245 |